OverviewChartNewsTraderScreen

Morgan Stanley Call 640 LLY 20.12.../  DE000ME8T103  /

Stuttgart
05/07/2024  20:30:54 Chg.+0.05 Bid22:00:34 Ask22:00:34 Underlying Strike price Expiration date Option type
4.56EUR +1.11% -
Bid Size: -		 -
Ask Size: -		 ELI LILLY 640.00 - 20/12/2024 Call
TeleTrader 02/07 US FDA approves Eli Lilly's Alzheimer's drug
GlobeNewswire 01/07 Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studyi...
GlobeNewswire 28/06 Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combin...
TeleTrader 25/06 Lilly partners with OpenAI to combat drug-resistance bacteria
GlobeNewswire 21/06 HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
GlobeNewswire 19/06 Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
GlobeNewswire 17/06 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 17/06 Atossa Set to Join Russell 3000® Index Effective June 28, 2024
GlobeNewswire 14/06 TScan Therapeutics Announces Updates to its Board of Directors
GlobeNewswire 12/06 US Gastroenterologists Express Anticipation for Approval of AbbVie’s Skyrizi in Ulcerative Colitis, ...
GlobeNewswire 11/06 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 11/06 Skyhawk Therapeutics Promotes Clint Musil to Chief Executive Officer and Appoints Co-founder Bill Ha...
GlobeNewswire 11/06 Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...
GlobeNewswire 11/06 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
TeleTrader 10/06 FDA advisors endorse Eli Lilly's Alzheimer's drug
Newsfile Corp 10/06 Guest Invitation to Momentum AI Summit in July
GlobeNewswire 10/06 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...
GlobeNewswire 10/06 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire 06/06 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
GlobeNewswire 06/06 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
TeleTrader 05/06 Alphabet appoints Anat Ashkenazi as new CFO
GlobeNewswire 04/06 CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Pres...
GlobeNewswire 03/06 BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Disease...
GlobeNewswire 03/06 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
GlobeNewswire 30/05 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024